A Study of 18F-AV-45 in Healthy Volunteers
Completed · Phase 1
Conditions studied: Alzheimer Disease
In brief
This study will determine how florbetapir F 18 (18F-AV-45) radioactivity is distributed throughout the body.
Key facts
- Study ID
- NCT01564706
- Run by
- Avid Radiopharmaceuticals
- People needed
- 9
- Starts
- 2007-10-01
- Expected to finish
- 2008-01-01
- Last updated by the study team
- 2012-05-18
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Able to lie still on the imaging table for periods up to 1 hour
You may not qualify if…
- Radiation exposure for experimental purposes within the last year
- Claustrophobic or otherwise unable to tolerate the imaging procedure
- Medical condition or surgical history that would confound evaluation
- Current clinically significant cardiovascular disease
- Received an investigational medication within the last 30 days
Where it is running
- Research Site — Jenkintown, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.